Publicaciones en colaboración con investigadores/as de Sarah Cannon Research Institute (2)

2024

  1. Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study

    Gynecologic Oncology, Vol. 185, pp. 202-211

2023

  1. Oral Selinexor as Maintenance Therapy After First-Line Chemotherapy for Advanced or Recurrent Endometrial Cancer

    Journal of Clinical Oncology